These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis]. Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074 [TBL] [Abstract][Full Text] [Related]
23. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis. Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205 [TBL] [Abstract][Full Text] [Related]
24. Primary biliary cirrhosis with antibody against carbonic anhydrase II associates with distinct immunological backgrounds. Ueno Y; Ishii M; Igarashi T; Mano Y; Yahagi K; Kisara N; Kobayashi Y; Niitsuma H; Kobayashi K; Shimosegawa T Hepatol Res; 2001 May; 20(1):18-27. PubMed ID: 11282483 [TBL] [Abstract][Full Text] [Related]
25. The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis. Tanaka A; Miyakawa H; Luketic VA; Kaplan M; Storch WB; Gershwin ME Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):295-9. PubMed ID: 12030434 [TBL] [Abstract][Full Text] [Related]
26. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis]. Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342 [No Abstract] [Full Text] [Related]
27. Do autoantibodies predict autoimmune liver disease in primary Sjögren's syndrome? Data of 180 patients upon a 5 year follow-up. Csepregi A; Szodoray P; Zeher M Scand J Immunol; 2002 Dec; 56(6):623-9. PubMed ID: 12472675 [TBL] [Abstract][Full Text] [Related]
28. [Atypical primary biliary cirrhosis or autoimmune cholangitis?]. Primo J; Miralles A; Ferrando J; Albert A; Julve R; Gómez A; García L Gastroenterol Hepatol; 1999 Dec; 22(10):505-9. PubMed ID: 10650665 [TBL] [Abstract][Full Text] [Related]
29. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720 [TBL] [Abstract][Full Text] [Related]
32. [Autoimmune hepatitis and overlap syndrome: diagnosis]. Berg PA; Klein R Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264 [TBL] [Abstract][Full Text] [Related]
33. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis. Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370 [TBL] [Abstract][Full Text] [Related]
34. Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms. Bombaci M; Pesce E; Torri A; Carpi D; Crosti M; Lanzafame M; Cordiglieri C; Sinisi A; Moro M; Bernuzzi F; Gerussi A; Geginat J; Muratori L; Terracciano LM; Invernizzi P; Abrignani S; Grifantini R Liver Int; 2019 Nov; 39(11):2124-2135. PubMed ID: 31033124 [TBL] [Abstract][Full Text] [Related]
35. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Bandin O; Courvalin JC; Poupon R; Dubel L; Homberg JC; Johanet C Hepatology; 1996 May; 23(5):1020-4. PubMed ID: 8621127 [TBL] [Abstract][Full Text] [Related]
36. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome. Kino-Ohsaki J; Nishimori I; Morita M; Okazaki K; Yamamoto Y; Onishi S; Hollingsworth MA Gastroenterology; 1996 May; 110(5):1579-86. PubMed ID: 8613065 [TBL] [Abstract][Full Text] [Related]
37. Genetic Risk Factors for Autoimmune Thyroid Disease might Affect the Susceptibility to and Modulate the Progression of Primary Biliary Cholangitis. Kuś A; Arłukowicz-Grabowska M; Szymański K; Wunsch E; Milkiewicz M; Płoski R; Shums Z; Norman GL; Milkiewicz P; Bednarczuk T; Krawczyk M J Gastrointestin Liver Dis; 2017 Sep; 26(3):245-252. PubMed ID: 28922436 [TBL] [Abstract][Full Text] [Related]
38. A study of anti-carbonic anhydrase II antibodies in rheumatic autoimmune diseases. Ono M; Ono M; Watanabe K; Miyashita Y; Inagaki Y; Ueki H J Dermatol Sci; 1999 Nov; 21(3):183-6. PubMed ID: 10527380 [TBL] [Abstract][Full Text] [Related]
39. A spectrum of histopathologic findings in autoimmune liver disease. Terracciano LM; Patzina RA; Lehmann FS; Tornillo L; Cathomas G; Mhawech P; Vecchione R; Bianchi L Am J Clin Pathol; 2000 Nov; 114(5):705-11. PubMed ID: 11068543 [TBL] [Abstract][Full Text] [Related]